ClinicalTrials.govpublic full text
Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma
melanoma, bevacizumab, ipilimumab, unresectable stage iii melanoma, unresectable stage iv melanoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805180
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.